Therefore, to clarify the role of the PRPGINS PgR polymorphism in female reproductive cancers, we performed a meta-analysis of all eligible case–control studies to derive the overall cancer risk associated with this polymorphism. The gene discussed is PGR; the disease is female reproductive organ cancer.